Skip To Main Content
Dania Akbar on Muck Rack

Dania Akbar

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dania

Contact Dania, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges

|
By Kevin Wu, Dania Akbar, Michel Giunta, Ananda Kalevar
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (118) Issue with article?

A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions

|
By Kevin Wu, Kenneth Tan, Dania Akbar, Mazen Y. Choulakian
| MDPI
1. Introduction Managing uveitis and neuro-ophthalmologic conditions presents a significant challenge due to the eye’s complex anatomy, which restricts effective medication delivery. Conventional therapies such as topical eye drops and intravitreal injections face limitations due to their poor bioavailability, short residence time, and the need for frequent dosing. To circumvent these constraints, the development of biodegradable nano-based drug delivery systems (DDS) has gained prominence.
Open in Who Shared Issue with article?

Revolutionizing Treatment for Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery System

|
By Kevin Wu, Simon Tran, Maxine Joly-Chevrier, Dania Akbar
| MDPI
1. Introduction The treatment of posterior segment eye diseases presents a major challenge due to the complex anatomy of the eye, which acts as a barrier to the effective delivery of medications. Conventional treatments, such as topical eye drops or intravitreal injections, are limited by their poor bioavailability and short residence time, requiring frequent dosing to manage the disease.
Open in Who Shared Issue with article?
See all 3 articles